Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists.
about
Molecular action of methotrexate in inflammatory diseasesAdenosine receptors: therapeutic aspects for inflammatory and immune diseases.Shaping of monocyte and macrophage function by adenosine receptorsThe PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritisEmerging adenosine receptor agonistsCyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.Gene expression profile of mouse myocardium with transgenic overexpression of A1 adenosine receptors.The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis.IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responsesExpression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes.Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?Methylthioadenosine reprograms macrophage activation through adenosine receptor stimulationAdenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation.A₃ adenosine receptor allosteric modulator induces an anti-inflammatory effect: in vivo studies and molecular mechanism of action.A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsisTyrosine nitration: localisation, quantification, consequences for protein function and signal transduction.Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.1-Methyl-tryptophan synergizes with methotrexate to alleviate arthritis in a mouse model of arthritis.Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis.Adenosine in fibrosis.A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.Acute adenosinergic cardioprotection in ischemic-reperfused hearts.Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.Pharmacological and therapeutic effects of A3 adenosine receptor agonistsRegulation of macrophage function by adenosine.Adenosine in inflammatory joint diseases.Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors.Anti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A2 receptors.The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in mice.Role of nonsynaptic communication in regulating the immune response.Adenosine receptor activation ameliorates type 1 diabetes.Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD.Investigational A₃ adenosine receptor targeting agents.Regulation of inflammation by adenosine.Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma.Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages
P2860
Q24534771-9279050E-F083-4148-9FAF-8BF4BD4CD4D2Q24651475-753AFB0F-DC09-4C69-917A-C0F97BFD5A79Q24655330-E37FF858-B091-481A-A129-AAD057CCED2EQ28195442-340C6747-0A4E-4198-AB66-B02E8D4AAA27Q28249111-BD6F00BD-2651-4F62-A540-13617AD92AC6Q28354178-45C3CE7D-0C45-4CA2-A301-04F3724E8046Q30310144-39FE784D-9061-4E97-87F0-9A943585CFAFQ30409961-61C6D867-A5ED-4440-9712-A804A86692F9Q31132502-AB3800AD-6BFA-4AD9-9DD7-FD76E2D84A0FQ33716470-E61E8F7B-5791-4405-A4B1-D646097F4BB9Q33812773-9555C752-11C4-439A-91E2-4B0E307D5C8BQ33834162-43DC123C-9E68-4EE6-B74C-83279984C5B7Q34035329-452DA2D3-DF88-4829-BFEC-1E747D8BB3B8Q34043933-1558A8E3-E591-4374-ACEC-30BE01F6F879Q34412639-2E72CD31-E160-40DB-9E22-7656EDA38337Q34418996-2D0EB0BA-A490-4EB1-87A1-A7963F9AA746Q34430029-E0AB6417-5AE3-47EB-9D93-BCFB1B336296Q34520643-AD4399BC-4414-4205-8450-C086A53AAA59Q34541409-CC6EEA09-B819-4E74-92CF-10F93F9C84C1Q34765028-E6C13E21-BF27-4838-ABFE-1380FC271BE0Q34896844-30428BB3-414D-4CE9-A607-14CD1417AF23Q35085245-9413D1DF-154C-49D7-87E1-F59982259F91Q35235736-7D74EA11-DD55-474A-A2F1-E9CFD26FD05FQ35560907-845BD5C5-A456-4F06-9B06-BAAFE8734035Q35630047-ED9C1492-E250-4706-849C-A26177E05068Q35747988-E00CA27E-D69B-4F4F-BE4E-7CAC00A20232Q35788500-DF18CD54-474F-47A6-BDC3-B7AFFB463D69Q36070200-5734FF0F-F735-4D39-9076-9424204FCC60Q36174251-18FC2ED0-4F46-439F-9489-3B04BEC8FFBBQ36202827-249C370F-6A44-4EE8-828A-3D5F55FCCC0CQ36362887-5545B3C3-10F1-4072-9A96-F44345C97DC9Q36426796-1F9EF389-6B4E-43DD-8921-3932471F7F4CQ36426971-1D1CD612-9575-4583-85CC-E95969A1E7DAQ36427003-B61D6325-3DB7-4B1C-9AA0-A1D449992B6AQ36457546-E1552BD2-264D-4C6D-9A5D-D59DDF97A670Q36731575-D39E60B7-B14B-4605-B3AB-6317D1C224E6Q36746981-ED219993-234D-4AF3-81AC-C87DB08102CEQ37084901-18BBE345-82C2-4637-8BA5-8C66DEE11B88Q37118787-88F0A540-96AB-4A27-AFC7-210D4E163850Q37309945-6F4898DB-E231-4453-856C-B265D7C9B885
P2860
Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Suppression of macrophage infl ...... y adenosine receptor agonists.
@ast
Suppression of macrophage infl ...... y adenosine receptor agonists.
@en
type
label
Suppression of macrophage infl ...... y adenosine receptor agonists.
@ast
Suppression of macrophage infl ...... y adenosine receptor agonists.
@en
prefLabel
Suppression of macrophage infl ...... y adenosine receptor agonists.
@ast
Suppression of macrophage infl ...... y adenosine receptor agonists.
@en
P2093
P356
P1476
Suppression of macrophage infl ...... y adenosine receptor agonists.
@en
P2093
A L Salzman
G Egnaczyk
T P Shanley
P304
P356
10.1038/SJ.BJP.0702040
P407
P577
1998-09-01T00:00:00Z